Risk Of Developing Liver Cancer After HCV Treatment

Wednesday, April 22, 2015

Gilead uses Georgia as free-drug testbed for hepatitis C elimination

Gilead uses Georgia as free-drug testbed for hepatitis C elimination

LONDON | BY BEN HIRSCHLER
(Reuters) - Gilead Sciences is seeking to convince governments and multilateral agencies worldwide that hepatitis C can be eliminated with a demonstration project in Georgia offering free drugs to all those who need them.

The unprecedented program will make the Caucasian country a testbed for uprooting the liver-destroying disease, using Gilead's highly effective but costly pill Sovaldi, plus its newer product Harvoni once approved.....
Continue reading...

Seeking Alpha
Gilead hopes to drive international demand for hep C drugs by giving some away
Apr 22 2015, 14:01 ET | About: Gilead Sciences, Inc. (GILD) |
By: Douglas W. House, SA News
Gilead Sciences (GILD -0.9%) is making a bid to convince governments and multilateral agencies that hepatitis C can be eliminated. It seeks to stimulate funding to support the aim along the same lines as the multi-national efforts to curtail AIDS, tuberculosis and malaria. It intends to do this by giving away Sovaldi (sofosbuvir) and Harvoni (ledipasvir/sofosbuvir) to all patients who need them in the Caucasian country of Georgia...


No comments:

Post a Comment